BetaShares S&P/ASX Australian Technology ETF (ATEC)
CXA 
Summary
Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript
Alphatec Holdings, Inc. (ATEC) Q2 2026 Earnings Call Transcript
Alphatec (ATEC) Q2 Earnings Lag Estimates
Alphatec (ATEC) came out with quarterly earnings of $0.07 per share, missing the Zacks Consensus Estimate of $0.09 per share. This compares to earnings of $0.02 per share a year ago.
Alphatec Q2 Earnings Call Highlights
Alphatec NASDAQ: ATEC reported second-quarter 2026 revenue of $214 million, up 15% from a year earlier, as growth in surgical procedures and surgeon adoption supported higher profitability and positive free cash flow.
BetaShares S&P/ASX Australian Technology ETF (ATEC) FAQ
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has BetaShares S&P/ASX Australian Technology ETF ever had a stock split?
BetaShares S&P/ASX Australian Technology ETF Profile
| CXA Exchange | US Country |
Overview
Alphatec Holdings, Inc., founded in 1990 and headquartered in Carlsbad, California, is a distinguished medical technology company focused on the design, development, and commercialization of innovative technologies for the surgical treatment of spinal disorders. Operating both in the United States and internationally, Alphatec manufactures and supplies its revolutionary products through a combination of third-party suppliers, independent sales agents, and direct sales representatives. The company's commitment to advancing spinal surgery technologies has positioned it as a leader in its field, offering a wide range of solutions aimed at improving patient outcomes.
Products and Services
- Alpha InformatiX Product Platform – A comprehensive suite of solutions that includes:
- EOS imaging system: Offers full-body imaging for enhanced diagnostic capabilities.
- VEA alignment mobile application: Leverages EOS technology, enabling quick quantification of alignment parameters on mobile devices.
- SafeOp Neural InformatiX System: Automates electromyographic and somatosensory evoked potential monitoring for increased safety.
- Valence: Integrates navigation and robotics into spine procedures, optimizing surgical outcomes.
- Sigma Prone TransPsoas (PTP) Access and PTP Patient Positioning Systems – Designed to improve accessibility and patient positioning during surgery.
- Spinal Implants and Fixation Systems – Includes:
- NanoTec surface modifications: Enhance implant integration and stability.
- Calibrate PSX and Invictus: Offer advanced spinal fixation solutions.
- Standalone implants: Provide options for height restoration and stabilization.
- Biological Solutions – A diverse portfolio of biologics designed to support spinal surgery and healing, comprising:
- 3D ProFuse Osteoconductive Bioscaffold: Facilitates ease of handling and improved endplate contact.
- AlphaGRAFT Demineralized Bone Matrix (DBM): Utilizes demineralized human tissues for bone grafting.
- AlphaGRAFT DBM Fibers: Offers demineralized fibers for versatile use in bone grafts.
- AlphaGRAFT Cellular Bone Matrix (CBM): A growth factor-enriched cellular bone matrix available in various forms for different surgical needs.
- BioCORE Moldable Bioactive Graft: A moldable, synthetic mineral-collagen composite matrix designed to fit bone defects.
- Amnioshield Amniotic Tissue Barrier: An allograft used for spinal surgical barrier applications.
